Categories: News

LENSAR to Present at the Oppenheimer MedTech, Tools, & Diagnostics Summit

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that Nick Curtis, Chief Executive Officer will present at the Oppenheimer MedTech, Tools, & Diagnostics Summit on May 26, 2021.

Mr. Curtis’ presentation will be available on-demand beginning at 8:00 a.m. Eastern Time on May 26, 2021 and can be accessed through the Investors section of the Company’s website at https://ir.lensar.com. The webcast will be available for two weeks after the presentation has been posted.

About LENSAR

LENSAR is a commercial-stage medical device company focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining better visual outcomes, efficiency and reproducibility by providing advanced imaging, simplified procedure planning, efficient design and precision.

Contacts

Thomas R. Staab, II, CFO

ir.contact@lensar.com

Lee Roth / Cameron Radinovic

Burns McClellan for LENSAR

lroth@burnsmc.com / cradinovic@burnsmc.com

Staff

Recent Posts

Croom Lawrence Joins Hemostemix with Revenue Share Agreement and VesCell.Health Launch

Calgary, Alberta--(Newsfile Corp. - June 27, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF), a…

5 hours ago

Hazelden Betty Ford Mourns the Loss of Addiction Advocate Bill Moyers

Center City, Minnesota--(Newsfile Corp. - June 27, 2025) - The Hazelden Betty Ford Foundation expresses…

5 hours ago

Trella Health Launches Its Latest Medicare Advantage (MA) Data to Help Post-Acute Providers Thrive in the Expanding MA Market

Now available in Marketscape Insights, this upgraded dataset delivers greater visibility into Medicare Advantage referral…

5 hours ago

Qaelon Medical Establishes Data Advisory Board to Revolutionize Surgical Leak Detection

STRASBOURG, France, June 27, 2025 /PRNewswire/ -- Qaelon Medical, a pioneer in real-time surgical leak…

5 hours ago

Jesse Draper’s Halogen Ventures Announces the Close of $30 Million Fund to Invest in Childcare and the Future of Family

Third fund taps into a $7.5 trillion dollar market opportunity to provide solutions for modern…

5 hours ago

Core Solutions & OPEN MINDS Announce Launch of AI Advisory Board to Revolutionize Behavioral Health with Ethical AI Practices

KING OF PRUSSIA, Pa., June 27, 2025 /PRNewswire/ -- Core Solutions (Core), a leader in AI-enhanced…

5 hours ago